ME00242B - Formulacija rastvora za inhalaciju sa soli tiotropijuma - Google Patents

Formulacija rastvora za inhalaciju sa soli tiotropijuma

Info

Publication number
ME00242B
ME00242B MEP-2008-407A MEP40708A ME00242B ME 00242 B ME00242 B ME 00242B ME P40708 A MEP40708 A ME P40708A ME 00242 B ME00242 B ME 00242B
Authority
ME
Montenegro
Prior art keywords
formulation containing
solution formulation
tiotropium salt
inhalative solution
inhalative
Prior art date
Application number
MEP-2008-407A
Other languages
German (de)
English (en)
French (fr)
Unknown language (me)
Inventor
Christel Schmelzer
Petra Barth
Karin Drechsel
Humke Barbara Niklaus
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7661727&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME00242(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MEP40708A publication Critical patent/MEP40708A/xx
Publication of ME00242B publication Critical patent/ME00242B/me

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
MEP-2008-407A 2000-10-31 2001-10-24 Formulacija rastvora za inhalaciju sa soli tiotropijuma ME00242B (me)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10054042 2000-10-31
YU33103A YU33103A (sh) 2000-10-31 2001-10-24 Formulacija rastvora za inhalaciju sa soli tiotropijuma
PCT/EP2001/012296 WO2002036591A2 (de) 2000-10-31 2001-10-24 Inhalative lösungsformulierung mit einem tiotropiumsalz

Publications (2)

Publication Number Publication Date
MEP40708A MEP40708A (en) 2011-02-10
ME00242B true ME00242B (me) 2011-05-10

Family

ID=7661727

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2008-407A ME00242B (me) 2000-10-31 2001-10-24 Formulacija rastvora za inhalaciju sa soli tiotropijuma

Country Status (33)

Country Link
EP (1) EP1335729A2 (es)
JP (1) JP4559703B2 (es)
KR (1) KR100983208B1 (es)
CN (1) CN1237970C (es)
AR (1) AR038765A1 (es)
AU (2) AU2174102A (es)
BG (1) BG66425B1 (es)
BR (1) BR0115016A (es)
CA (1) CA2427583C (es)
CZ (1) CZ305033B6 (es)
DE (1) DE10152369A1 (es)
EA (1) EA009068B1 (es)
EC (1) ECSP034570A (es)
EE (1) EE05343B1 (es)
HK (1) HK1060569A1 (es)
HR (1) HRP20030337A2 (es)
HU (1) HUP0301377A3 (es)
IL (2) IL155676A0 (es)
ME (1) ME00242B (es)
MX (1) MXPA03003750A (es)
MY (1) MY132777A (es)
NO (1) NO332524B1 (es)
NZ (1) NZ526024A (es)
PE (1) PE20020518A1 (es)
PL (1) PL361001A1 (es)
SA (1) SA01220503B1 (es)
SK (1) SK288031B6 (es)
TW (1) TWI296934B (es)
UA (1) UA76435C2 (es)
UY (1) UY26991A1 (es)
WO (1) WO2002036591A2 (es)
YU (1) YU33103A (es)
ZA (1) ZA200303045B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60114865T2 (de) 2000-04-28 2006-07-27 Kosan Biosciences, Inc., Hayward Heterologe herstellung von polyketiden
US20030235538A1 (en) 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
AU2004279438A1 (en) * 2003-10-09 2005-04-21 Inverseon, Inc. Methods for treating diseases and conditions with inverse agonists
SE0303269L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Medicinsk produkt
CA2595791C (en) * 2005-03-16 2013-10-08 Meda Pharma Gmbh & Co. Kg The combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
US20070274925A1 (en) * 2006-05-26 2007-11-29 Dey, L.P. Nebulizable compositions of quaternary ammonium muscarinic receptor antagonists
CN100446770C (zh) * 2007-01-10 2008-12-31 上海现代药物制剂工程研究中心有限公司 丙酸培氯米松水雾剂
TR200907237A2 (tr) * 2009-09-23 2011-04-21 Bi̇lgi̇ç Mahmut Tiotropyum kuru toz kombinasyonu
CN116173025A (zh) * 2018-07-26 2023-05-30 四川海思科制药有限公司 一种含格隆铵盐及茚达特罗盐的气雾剂药物组合物及其制备方法与应用
CN111971034A (zh) * 2018-07-26 2020-11-20 四川海思科制药有限公司 一种含格隆铵盐的气雾剂药物组合物及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
DE4203306A1 (de) * 1992-02-06 1993-08-12 Ig Spruehtechnik Gmbh Asthma oder pulmonal-aerosolzubereitungen mit lecithin
DK0835098T3 (da) * 1995-06-27 2002-10-07 Boehringer Ingelheim Pharma Stabilt lægemiddelpræparat til frembringlese af drivgasfrie aerosoler
US5824669A (en) * 1996-03-22 1998-10-20 Nitromed, Inc. Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
BR9709650A (pt) * 1996-06-04 1999-08-10 Procter & Gamble Aerosol nasal contendo um esteróide intransal e um anti-histamínico
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
JPH10298107A (ja) * 1997-04-25 1998-11-10 Taisho Pharmaceut Co Ltd 医薬組成物
DK1102579T3 (da) * 1998-08-04 2003-07-14 Jago Res Ag Medicinske aerosolformuleringer
DE19847968A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen

Also Published As

Publication number Publication date
CZ20031487A3 (cs) 2003-09-17
YU33103A (sh) 2006-05-25
MEP40708A (en) 2011-02-10
AU2174102A (en) 2002-05-15
BR0115016A (pt) 2005-05-03
SK5262003A3 (en) 2003-10-07
AU2002221741B2 (en) 2007-04-05
EE200300202A (et) 2003-10-15
CN1473044A (zh) 2004-02-04
KR100983208B1 (ko) 2010-09-20
CA2427583C (en) 2008-02-12
HUP0301377A2 (hu) 2003-10-28
DE10152369A1 (de) 2002-05-08
NO332524B1 (no) 2012-10-08
PL361001A1 (en) 2004-09-20
CA2427583A1 (en) 2002-05-10
MXPA03003750A (es) 2004-10-15
EP1335729A2 (de) 2003-08-20
AR038765A1 (es) 2005-01-26
SK288031B6 (sk) 2012-12-03
EA009068B1 (ru) 2007-10-26
NO20031914L (no) 2003-06-23
NO20031914D0 (no) 2003-04-29
PE20020518A1 (es) 2002-07-12
MY132777A (en) 2007-10-31
NZ526024A (en) 2005-10-28
WO2002036591A3 (de) 2002-07-25
SA01220503B1 (ar) 2007-03-10
HRP20030337A2 (en) 2005-04-30
BG107726A (bg) 2004-11-30
HK1060569A1 (en) 2004-08-13
CZ305033B6 (cs) 2015-04-08
IL155676A (en) 2012-05-31
UY26991A1 (es) 2002-06-20
UA76435C2 (en) 2006-08-15
ECSP034570A (es) 2003-06-25
IL155676A0 (en) 2003-11-23
WO2002036591A2 (de) 2002-05-10
TWI296934B (en) 2008-05-21
JP2004523482A (ja) 2004-08-05
JP4559703B2 (ja) 2010-10-13
KR20040010552A (ko) 2004-01-31
EE05343B1 (et) 2010-10-15
BG66425B1 (bg) 2014-04-30
ZA200303045B (en) 2004-04-22
EA200300483A1 (ru) 2003-12-25
HUP0301377A3 (en) 2005-12-28
CN1237970C (zh) 2006-01-25

Similar Documents

Publication Publication Date Title
ME00242B (me) Formulacija rastvora za inhalaciju sa soli tiotropijuma
CY1108137T1 (el) Συνθεση για εισπνευστηρα δοσομετρημενης δοσης που χρησιμοποιει υδρο-φθορο-αλκανια ως προωθητικα
EP1248612A4 (en) NEW SUBSTANCES AND COMPOUNDS AS PROTEASE INHIBITORS
NO20062877L (no) Stabile liposomsammensetninger som omfatter lipofile aminholdige farmasoytiske midler
ECSP077402A (es) Derivados de 2-amido-4-feniltiazol, su preparación y su aplicación en terapéutica
PL1933809T3 (pl) Kompozycje do dostarczania donosowego
ECSP066541A (es) Nuevos derivados de piridazin-3(2h)-ona
MXPA02012903A (es) Derivados de colquinol como inhibidores de angiogenesis.
ME00244B (me) Formulacija rastvora za inhalaciju sa soli tiotropijma
MY153023A (en) Tropane derivatives useful in therapy
CR8842A (es) Derivados de pirido-pirimidina, su preparacion, su aplicacion en terapeutica
EP1340755A4 (en) AGENT WITH EFFECT AGAINST HELICOBACTER
EA200600528A1 (ru) Способ получения водорастворимых дитерпенов и их применение
MXPA03011480A (es) Una preparacion farmaceutica acuosa de cilostazol para uso parenteral.
DOP2001000268A (es) Derivados puente de piperazina
HRP20040932B1 (hr) Formulacija aerosola za inhalaciju koja sadrži tiotropijevu sol
AR035285A1 (es) Formulaciones en combinacion de derivados de1,4-benzotiepina-1,1-dioxido con otras sustancias activas, y su utilizacion.
AR030788A1 (es) Antagonistas de receptores de taquiquinina zwitterionica
HUP0201700A2 (hu) Stabil xilometazolin- és oximetazolin-oldat, alkalmazásuk gyógyszerkészítmény előállítására és ezeket tartalmazó gyógyszerkészítmény
HN2001000021A (es) Nuevos derivados de amidas heterociclicas
AR031720A1 (es) Benzimidazoles n-alcoxialquil sustituidos, proceso para su preparacion, composiciones, y uso de estos compuestos para preparar composiciones antiparasitarias
PT1150660E (pt) Formulacao farmaceutica efervescente contendo metamizole
ES2166306B1 (es) Composicion desinfectante tensioactiva.
CO4340562A1 (es) Mezcla para para inhibir la formacion y/o disminuir la concentracion de nitrosamina